Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Short-Term US Funding Bill Passes With $1.1bn In Emergency Zika Funds

Executive Summary

Congress managed to settle its disputes over funding riders Sept. 28 and passed a relatively clean bill that contains $1.1bn in emergency Zika virus response funding, and will keep government agencies – including US FDA – running at current spending levels until Dec. 9.

Advertisement

Related Content

Diagnostics In 2016: From Alere To Zika
Medical Innovation Bills On Fast Track In Congress, But Some Barriers Remain
Zika Assay Reviews Are Testing The Limits Of FDA Capacity, Shuren Says
Hologic/Grifols, Roche Molecular Zika Tests Tapped For Blood-Screening Ramp-Up
House-Senate Conferees Fight Over Zika Funds As FDA Approves More Assays

Topics

Advertisement
UsernamePublicRestriction

Register

MT103896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel